Apogee Therapeutics, LLC is a biotechnology company advancing novel, potentially best-in-class therapies to address the needs of the millions of people living with immunological and inflammatory disorders.
Location: United States
Employees: 1-10
Total raised: $632M
Founded date: 2022
Investors 2
| Date | Name | Website |
| 27.11.2023 | Access Bio... | accessbio-... |
| 30.08.2023 | OrbiMed | orbimed.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 12.03.2024 | - | $483M | - |
| 12.12.2022 | Series B | $149M | - |
Mentions in press and media 15
| Date | Title | Description |
| 07.07.2026 | Buy these quality, low-stress stocks for the summer, says Jefferies | Markets have become more volatile as investors debate whether big tech companies are getting enough return on their AI spending. The S&P 500 momentum index has outperformed the wider market by more than 70% since 2024, close to levels s... |
| 26.06.2026 | US Markets Waver: Oil Falls, Tech Sinks Amid Fed Rate Fears | US markets faced a turbulent Monday. Oil prices fell sharply following diplomatic progress with Iran and temporary sanction waivers. This eased fears of energy-driven inflation. Bond yields still surged, however, on expectations of Federal ... |
| 22.06.2026 | Stocks making the biggest moves premarket: Apogee Therapeutics, SpaceX, Arcosa & more | - |
| 22.06.2026 | US stocks drift after oil prices ease and Big Tech stocks fall | Getting your Trinity Audio player ready... By STAN CHOE, AP Business Writer NEW YORK (AP) — U.S. stocks drifted through a mixed day of trading on Monday after oil prices eased and falling Big Tech stocks weighed on Wall Street. The S&P ... |
| 22.06.2026 | Stocks making the biggest moves midday: Alphabet, AeroVironment, Salesforce, Apogee Therapeutics & more | - |
| 21.06.2026 | Daily Stock Market Live Stock futures are little changed as investors weigh Iran deal progress: Live updates | U.S. equity futures were little changed Monday as Wall Street assessed the latest developments in the Iran war negotiations and awaits the release of inflation data closely watched by the Federal Reserve. S&P 500 futures traded down 0.1... |
| 28.05.2026 | Apogee Therapeutics: $1.3 Billion Blackstone Financing To Advance Zumilokibart Phase 3 Development | Apogee Therapeutics announced a strategic financing collaboration with Blackstone Life Sciences worth up to $1.3 billion to support the Phase 3 development and potential commercialization of zumilokibart, the company’s lead treatment candid... |
| 13.03.2024 | Apogee Therapeutics, Inc. Closes Public Offering with Record Proceeds | Apogee Therapeutics, Inc. (Nasdaq: APGE) has successfully completed a public offering, raising a staggering $483 million in gross proceeds. The company, known for its innovative biologics targeting various inflammatory and immunology indica... |
| 12.03.2024 | Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million | - |
| 12.03.2024 | Apogee Therapeutics, Inc. Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $483 Million | SAN FRANCISCO, Calif. and WALTHAM, Mass., March 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis... |
Show more